BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cai H, Yang X, Gao Y, Xu Z, Yu B, Xu T, Li X, Xu W, Wang X, Hua L. Exosomal MicroRNA-9-3p Secreted from BMSCs Downregulates ESM1 to Suppress the Development of Bladder Cancer. Mol Ther Nucleic Acids 2019;18:787-800. [PMID: 31734559 DOI: 10.1016/j.omtn.2019.09.023] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 7.3] [Reference Citation Analysis]
Number Citing Articles
1 Zhou Y, Yang L, Bo C, Zhang X, Zhang J, Li Y. MicroRNA-9-3p Aggravates Cerebral Ischemia/Reperfusion Injury by Targeting Fibroblast Growth Factor 19 (FGF19) to Inactivate GSK-3β/Nrf2/ARE Signaling. Neuropsychiatr Dis Treat 2021;17:1989-2002. [PMID: 34177264 DOI: 10.2147/NDT.S290237] [Reference Citation Analysis]
2 Hernández-Barranco A, Nogués L, Peinado H. Could Extracellular Vesicles Contribute to Generation or Awakening of "Sleepy" Metastatic Niches? Front Cell Dev Biol 2021;9:625221. [PMID: 33738282 DOI: 10.3389/fcell.2021.625221] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Guan Q, Yuan B, Zhang X, Yan T, Li J, Xu W. Long non-coding RNA DUXAP8 promotes tumorigenesis by regulating IGF1R via miR-9-3p in hepatocellular carcinoma. Exp Ther Med 2021;22:755. [PMID: 34035852 DOI: 10.3892/etm.2021.10187] [Reference Citation Analysis]
4 Ge X, Liu W, Zhao W, Feng S, Duan A, Ji C, Shen K, Liu W, Zhou J, Jiang D, Rong Y, Gong F, Wang J, Xu Z, Li X, Fan J, Wei Y, Bai J, Cai W. Exosomal Transfer of LCP1 Promotes Osteosarcoma Cell Tumorigenesis and Metastasis by Activating the JAK2/STAT3 Signaling Pathway. Mol Ther Nucleic Acids 2020;21:900-15. [PMID: 32810692 DOI: 10.1016/j.omtn.2020.07.025] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
5 Wang F, Zhang Y, Zhou X, Chen X, Xiang J, Fan M, Yu Y, Cai Y, Wu H, Huang S, He N, Hu Z, Ding G, Jin X. Circular RNA CircPPP1CB Suppresses Tumorigenesis by Interacting With the MiR-1307-3p/SMG1 Axis in Human Bladder Cancer. Front Cell Dev Biol 2021;9:704683. [PMID: 34595165 DOI: 10.3389/fcell.2021.704683] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Shi Z, Wang K, Xing Y, Yang X. CircNRIP1 Encapsulated by Bone Marrow Mesenchymal Stem Cell-Derived Extracellular Vesicles Aggravates Osteosarcoma by Modulating the miR-532-3p/AKT3/PI3K/AKT Axis. Front Oncol 2021;11:658139. [PMID: 34660257 DOI: 10.3389/fonc.2021.658139] [Reference Citation Analysis]
7 Feng R, Li Z, Wang X, Ge G, Jia Y, Wu D, Ji Y, Wang C. Silenced lncRNA SNHG14 restrains the biological behaviors of bladder cancer cells via regulating microRNA-211-3p/ESM1 axis. Cancer Cell Int 2021;21:67. [PMID: 33482820 DOI: 10.1186/s12935-020-01717-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Cetin Z, Saygili EI, Görgisen G, Sokullu E. Preclinical Experimental Applications of miRNA Loaded BMSC Extracellular Vesicles. Stem Cell Rev Rep 2021;17:471-501. [PMID: 33398717 DOI: 10.1007/s12015-020-10082-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Zhao Y, Liu P, Tan H, Chen X, Wang Q, Chen T. Exosomes as Smart Nanoplatforms for Diagnosis and Therapy of Cancer. Front Oncol 2021;11:743189. [PMID: 34513718 DOI: 10.3389/fonc.2021.743189] [Reference Citation Analysis]
10 Eiro N, Fraile M, Fernández-Francos S, Sánchez R, Costa LA, Vizoso FJ. Importance of the origin of mesenchymal (stem) stromal cells in cancer biology: "alliance" or "war" in intercellular signals. Cell Biosci 2021;11:109. [PMID: 34112253 DOI: 10.1186/s13578-021-00620-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Sun Z, Zhang J, Li J, Li M, Ge J, Wu P, You B, Qian H. Roles of Mesenchymal Stem Cell-Derived Exosomes in Cancer Development and Targeted Therapy. Stem Cells Int 2021;2021:9962194. [PMID: 34335792 DOI: 10.1155/2021/9962194] [Reference Citation Analysis]
12 Hu Y, Zai H, Jiang W, Yao Y, Ou Z, Zhu Q. miR-126 in Extracellular Vesicles Derived from Hepatoblastoma Cells Promotes the Tumorigenesis of Hepatoblastoma through Inducing the Differentiation of BMSCs into Cancer Stem Cells. J Immunol Res 2021;2021:6744715. [PMID: 34746322 DOI: 10.1155/2021/6744715] [Reference Citation Analysis]
13 Zhang H, Shen YW, Zhang LJ, Chen JJ, Bian HT, Gu WJ, Zhang H, Chen HZ, Zhang WD, Luan X. Targeting Endothelial Cell-Specific Molecule 1 Protein in Cancer: A Promising Therapeutic Approach. Front Oncol 2021;11:687120. [PMID: 34109132 DOI: 10.3389/fonc.2021.687120] [Reference Citation Analysis]
14 Pan KF, Yang YC, Lee WJ, Hua KT, Chien MH. Proteoglycan Endocan: A multifaceted therapeutic target in Cancer. Biochim Biophys Acta Rev Cancer 2021;1877:188672. [PMID: 34953930 DOI: 10.1016/j.bbcan.2021.188672] [Reference Citation Analysis]
15 Jia CY, Xiang W, Liu JB, Jiang GX, Sun F, Wu JJ, Yang XL, Xin R, Shi Y, Zhang DD, Li W, Zuberi Z, Zhang J, Lu GX, Wang HM, Wang PY, Yu F, Lv ZW, Ma YS, Fu D. MiR-9-1 Suppresses Cell Proliferation and Promotes Apoptosis by Targeting UHRF1 in Lung Cancer. Technol Cancer Res Treat 2021;20:15330338211041191. [PMID: 34520284 DOI: 10.1177/15330338211041191] [Reference Citation Analysis]
16 Hekmatirad S, Moloudizargari M, Moghadamnia AA, Kazemi S, Mohammadnia-afrouzi M, Baeeri M, Moradkhani F, Asghari MH. Inhibition of Exosome Release Sensitizes U937 Cells to PEGylated Liposomal Doxorubicin. Front Immunol 2021;12:692654. [DOI: 10.3389/fimmu.2021.692654] [Reference Citation Analysis]
17 Geng H, Zhou Q, Guo W, Lu L, Bi L, Wang Y, Min J, Yu D, Liang Z. Exosomes in bladder cancer: novel biomarkers and targets. J Zhejiang Univ Sci B 2021;22:341-7. [PMID: 33973417 DOI: 10.1631/jzus.B2000711] [Reference Citation Analysis]
18 Shih KW, Chen WC, Chang CH, Tai TE, Wu JC, Huang AC, Liu MC. Non-Muscular Invasive Bladder Cancer: Re-envisioning Therapeutic Journey from Traditional to Regenerative Interventions. Aging Dis 2021;12:868-85. [PMID: 34094648 DOI: 10.14336/AD.2020.1109] [Reference Citation Analysis]
19 Zou J, Du J, Tu H, Chen H, Cong K, Bi Z, Sun J. Resveratrol benefits the lineage commitment of bone marrow mesenchymal stem cells into osteoblasts via miR-320c by targeting Runx2. J Tissue Eng Regen Med 2021;15:347-60. [PMID: 33481337 DOI: 10.1002/term.3176] [Reference Citation Analysis]
20 Liu W, Yang Y, He B, Ma F, Sun F, Guo M, Zhang M, Dong Z. ESM1 promotes triple-negative breast cancer cell proliferation through activating AKT/NF-κB/Cyclin D1 pathway. Ann Transl Med 2021;9:533. [PMID: 33987231 DOI: 10.21037/atm-20-7005] [Reference Citation Analysis]
21 Chang W, Xiao D, Fang X, Wang J. Phospholipids in small extracellular vesicles: emerging regulators of neurodegenerative diseases and cancer. Cytotherapy 2021:S1465-3249(21)00827-6. [PMID: 34742629 DOI: 10.1016/j.jcyt.2021.09.013] [Reference Citation Analysis]
22 Liu W, Wang B, Duan A, Shen K, Zhang Q, Tang X, Wei Y, Tang J, Zhang S. Exosomal transfer of miR-769-5p promotes osteosarcoma proliferation and metastasis by targeting DUSP16. Cancer Cell Int 2021;21:541. [PMID: 34663350 DOI: 10.1186/s12935-021-02257-4] [Reference Citation Analysis]
23 Liu H, Deng S, Han L, Ren Y, Gu J, He L, Liu T, Yuan ZX. Mesenchymal stem cells, exosomes and exosome-mimics as smart drug carriers for targeted cancer therapy. Colloids Surf B Biointerfaces 2021;209:112163. [PMID: 34736220 DOI: 10.1016/j.colsurfb.2021.112163] [Reference Citation Analysis]
24 Tong Y, Liu X, Xia D, Peng E, Yang X, Liu H, Ye T, Wang X, He Y, Xu H, Ye Z, Chen Z, Tang K. Biological Roles and Clinical Significance of Exosome-Derived Noncoding RNAs in Bladder Cancer. Front Oncol 2021;11:704703. [PMID: 34692482 DOI: 10.3389/fonc.2021.704703] [Reference Citation Analysis]
25 Wu L, Zhou W, Lin L, Chen A, Feng J, Qu X, Zhang H, Yue J. Delivery of therapeutic oligonucleotides in nanoscale. Bioact Mater 2022;7:292-323. [PMID: 34466734 DOI: 10.1016/j.bioactmat.2021.05.038] [Reference Citation Analysis]
26 Zhang H, Wang J, Ren T, Huang Y, Liang X, Yu Y, Wang W, Niu J, Guo W. Bone marrow mesenchymal stem cell-derived exosomal miR-206 inhibits osteosarcoma progression by targeting TRA2B. Cancer Lett 2020;490:54-65. [PMID: 32682951 DOI: 10.1016/j.canlet.2020.07.008] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 7.5] [Reference Citation Analysis]
27 Song X, Wang X, Liu Z, Yu Z. Role of GPX4-Mediated Ferroptosis in the Sensitivity of Triple Negative Breast Cancer Cells to Gefitinib. Front Oncol 2020;10:597434. [PMID: 33425751 DOI: 10.3389/fonc.2020.597434] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
28 Wahb AMSE, El Kassas M, Khamis AK, Elhelbawy M, Elhelbawy N, Habieb MSE. Circulating microRNA 9-3p and serum endocan as potential biomarkers for hepatitis C virus-related hepatocellular carcinoma. World J Hepatol 2021; 13(11): 1753-1765 [PMID: 34904043 DOI: 10.4254/wjh.v13.i11.1753] [Reference Citation Analysis]
29 Zhang JK, Zhang Z, Guo ZA, Fu Y, Chen XJ, Chen WJ, Wu HF, Cui XJ. The BMSC-derived exosomal lncRNA Mir9-3hg suppresses cardiomyocyte ferroptosis in ischemia-reperfusion mice via the Pum2/PRDX6 axis. Nutr Metab Cardiovasc Dis 2021:S0939-4753(21)00515-9. [PMID: 34953631 DOI: 10.1016/j.numecd.2021.10.017] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Huang YG, Wang Y, Zhu RJ, Tang K, Tang XB, Su XM. EMS1/DLL4-Notch Signaling Axis Augments Cell Cycle-Mediated Tumorigenesis and Progress in Human Adrenocortical Carcinoma. Front Oncol 2021;11:771579. [PMID: 34858850 DOI: 10.3389/fonc.2021.771579] [Reference Citation Analysis]
31 Sun Q, Zhang X, Tan Z, Gu H, Ding S, Ji Y. Bone marrow mesenchymal stem cells-secreted exosomal microRNA-205-5p exerts inhibitory effect on the progression of liver cancer through regulating CDKL3. Pathol Res Pract 2021;225:153549. [PMID: 34329837 DOI: 10.1016/j.prp.2021.153549] [Reference Citation Analysis]
32 Zhang X, Zhang H, Gu J, Zhang J, Shi H, Qian H, Wang D, Xu W, Pan J, Santos HA. Engineered Extracellular Vesicles for Cancer Therapy. Adv Mater 2021;33:e2005709. [PMID: 33644908 DOI: 10.1002/adma.202005709] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 12.0] [Reference Citation Analysis]